Financial Architects, Inc Intercept Pharmaceuticals, Inc. Call Options Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $15,554 - $24,136	-200 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $18,366 - $24,136	200 New	200 $22,000
Q2 2018 Aug 03, 2018	SELL	$60.0 - $85.67 $6,000 - $8,567	-100 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$52.72 - $67.25 $5,272 - $6,725	100 New	100 $6,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.